Suppr超能文献

肿瘤性人类组织肥大细胞表达黏附分子CD44/HCAM。

Neoplastic human tissue mast cells express the adhesion molecule CD44/HCAM.

作者信息

Horny H P, Menke D M, Kaiserling E

机构信息

Institut für Pathologie, Universität Tübingen, Germany.

出版信息

Virchows Arch. 1996 Oct;429(2-3):91-4. doi: 10.1007/BF00192430.

Abstract

Expression of the homing-associated cell adhesion molecule/HCAM (CD44) in normal/reactive and neoplastic human tissue mast cells (TMC) was determined immunohistochemically using the antibody DAKO-DF1485, which detects all isoforms of CD44. Studies were performed on 30 routinely processed specimens. Twenty of these, from bone marrow, skin, spleen, liver, lymph node and jejunal mucosa, contained infiltrates of TMC. These represented various types of generalized mastocytosis/systemic mast cell disease, including benign systemic mastocytosis. Ten specimens consisted of tissue with a marked reactive increase in TMC; most of these were lymph nodes with chronic nonspecific lymphadenitis and benign or malignant solid tumours. In all 30 specimens TMC exhibited an annular pattern of immunostaining, which was usually very strong. Both normal/reactive and neoplastic TMC exhibited consistent immunoreactivity with the antibody DAKO-DF1485, and this antibody may be of diagnostic value in the detection of atypical TMC associated with malignant mastocytosis. TMC and their neoplastic derivatives belong to a large family of mesenchymal and epithelial cells containing the principal surface receptor for hyaluronan.

摘要

采用抗体DAKO-DF1485,通过免疫组织化学方法测定归巢相关细胞黏附分子/HCAM(CD44)在正常/反应性及肿瘤性人组织肥大细胞(TMC)中的表达,该抗体可检测CD44的所有异构体。对30份常规处理的标本进行了研究。其中20份来自骨髓、皮肤、脾脏、肝脏、淋巴结和空肠黏膜,含有TMC浸润。这些代表了各种类型的全身性肥大细胞增多症/系统性肥大细胞疾病,包括良性系统性肥大细胞增多症。10份标本为由TMC显著反应性增加的组织组成;其中大多数是患有慢性非特异性淋巴结炎以及良性或恶性实体瘤的淋巴结。在所有30份标本中,TMC均呈现环状免疫染色模式,通常非常强烈。正常/反应性和肿瘤性TMC与抗体DAKO-DF1485均表现出一致的免疫反应性,并且该抗体在检测与恶性肥大细胞增多症相关的非典型TMC中可能具有诊断价值。TMC及其肿瘤衍生物属于包含透明质酸主要表面受体的一大类间充质和上皮细胞。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验